Effects of chitosan supplementation versus placebo on liver fat and metabolic parameters in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disorder affecting about one-third of the global population. It encompasses a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH) and may progress to fibrosis and cirrhosis. Chitosan oligosacchar...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-02-01
|
| Col·lecció: | Trials |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13063-026-09504-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|